ClinConnect ClinConnect Logo
Search / Trial NCT06105333

Fidgety Movements of Preterm Neonates Included in COSGOD III

Launched by MEDICAL UNIVERSITY OF GRAZ · Oct 23, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Near Infrared Spectroscopy Preterm Neonates Preterm Birth Cerebral Injury Cerebral Oxygenation Resuscitation Neurological Outcome Fidgety Movements General Movements

ClinConnect Summary

This clinical trial, called COSGOD III, is studying the movements of preterm babies, specifically looking at "fidgety movements" that occur between six to 20 weeks after their expected due date. Researchers want to understand how certain medical care, including a technique called Near-Infrared Spectroscopy (NIRS), might help improve brain health and movement in these infants. By comparing the movements of babies who received this specialized care to those who did not, the study aims to find out if there are any differences in their short-term brain development outcomes.

To participate in this study, infants must have been part of the COSGOD III trial and undergone regular checks of their fidgety movements during the specified time frame. The trial is currently recruiting participants, and both boys and girls are eligible. Families can expect that their baby's movements will be closely observed to gather information about their development after being discharged from the hospital, which could help improve care for future preterm infants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Preterm neonates included in the COSGOD III trial
  • Death
  • Routinely performed fidgety movement (FM) analysis between six to 20 weeks post term
  • Exclusion Criteria:
  • Neonates without FM analysis between six to 20 weeks post term

About Medical University Of Graz

The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.

Locations

Innsbruck, , Austria

Graz, , Austria

Patients applied

0 patients applied

Trial Officials

Gerhard Pichler, Prof.

Principal Investigator

Division of Neonatology, Medical University of Graz, Austria

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported